PULM RSI Chart
Last 7 days
7.9%
Last 30 days
-8.1%
Last 90 days
4.9%
Trailing 12 Months
-28.6%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 11.7M | 0 | 0 | 0 |
2023 | 6.4M | 6.9M | 6.8M | 7.3M |
2022 | 4.9M | 4.0M | 4.8M | 6.1M |
2021 | 11.3M | 10.0M | 6.7M | 5.2M |
2020 | 10.6M | 9.3M | 12.2M | 12.6M |
2019 | 0 | 5.0M | 6.4M | 8.0M |
2018 | 605.5K | 488.0K | 153.0K | 306.0K |
2017 | 0 | 0 | 773.5K | 513.5K |
2016 | 1.5M | 1.6M | 992.0K | 834.5K |
2015 | 143.0K | 309.0K | 930.0K | 1.2M |
2014 | 0 | 0 | 0 | 352.0K |
Which funds bought or sold PULM recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 15, 2024 | STATE STREET CORP | unchanged | - | -2,650 | 23,288 | -% |
May 15, 2024 | MORGAN STANLEY | unchanged | - | -3.00 | 44.00 | -% |
May 15, 2024 | SABBY MANAGEMENT, LLC | sold off | -100 | -100,790,000 | - | -% |
May 15, 2024 | Tower Research Capital LLC (TRC) | added | 45.88 | 2,474 | 9,114 | -% |
May 13, 2024 | UBS Group AG | unchanged | - | -18.00 | 289 | -% |
May 13, 2024 | GEODE CAPITAL MANAGEMENT, LLC | unchanged | - | -4,686 | 41,203 | -% |
May 13, 2024 | RENAISSANCE TECHNOLOGIES LLC | reduced | -2.13 | -17,000 | 201,000 | -% |
May 10, 2024 | WELLS FARGO & COMPANY/MN | added | 3.57 | -1.00 | 51.00 | -% |
May 10, 2024 | CITIGROUP INC | new | - | 189 | 189 | -% |
May 10, 2024 | TD Waterhouse Canada Inc. | new | - | 588 | 588 | -% |
Unveiling Pulmatrix Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Pulmatrix Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MRNA | 50.9B | 6.8B | -8.53 | 7.44 | ||||
HILS | 22.5B | 216.3K | -2.5K | 104.0K | ||||
ALNY | 18.9B | 2.0B | -56.9 | 9.43 | ||||
BMRN | 14.7B | 2.5B | 71.65 | 5.96 | ||||
INCY | 12.8B | 3.8B | 17.2 | 3.4 | ||||
MID-CAP | ||||||||
BBIO | 5.6B | 107.9M | -10.31 | 48.09 | ||||
APLS | 5.0B | 524.1M | -12.02 | 9.57 | ||||
AXSM | 3.6B | 251.0M | -12.28 | 14.5 | ||||
ARWR | 3.1B | 240.7M | -6.53 | 12.77 | ||||
ACAD | 2.4B | 813.8M | -1.4K | 3 | ||||
SMALL-CAP | ||||||||
CPRX | 1.9B | 411.3M | 29.91 | 4.73 | ||||
NVAX | 1.8B | 996.6M | -4.58 | 1.83 | ||||
CRBP | 480.9M | 881.7K | -14.25 | 481.06 | ||||
INO | 310.9M | 4.9M | -2.49 | 63.89 | ||||
IBIO | 17.1M | 2.1M | -0.74 | 7.61 |
Pulmatrix Inc News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2018Q4 |
Revenue | 167.3% | 5,885 | 2,202 | 1,753 | 1,844 | 1,499 | 1,708 | 1,872 | 1,331 | 1,160 | 456 | 1,069 | 2,254 | 1,390 | 2,000 | 4,372 | 3,500 | 2,762 | 1,609 | 1,406 | 4,819 | 153 |
Operating Expenses | 16.1% | 5,138 | 4,427 | 5,692 | 5,835 | 6,084 | 6,033 | 6,972 | 5,890 | 6,123 | 4,499 | 9,259 | 6,103 | 5,475 | 4,674 | 5,649 | 4,674 | 7,499 | 5,797 | 5,082 | 12,766 | 5,267 |
S&GA Expenses | -100.0% | - | 911 | 1,729 | 1,670 | 2,210 | 1,566 | 1,685 | 1,553 | 1,974 | 1,540 | 1,656 | 1,562 | 1,619 | 1,409 | 1,776 | 1,490 | 2,212 | 1,589 | 1,785 | 3,128 | 2,046 |
R&D Expenses | -0.1% | 3,512 | 3,516 | 3,963 | 4,165 | 3,874 | 4,467 | 5,287 | 4,337 | 4,149 | 2,959 | 4,026 | 4,541 | 3,856 | 3,265 | 3,873 | 3,184 | 5,287 | 4,208 | 3,297 | 3,164 | 3,221 |
Interest Expenses | -16.7% | 160 | 192 | 217 | 236 | 222 | 191 | 102 | 15.00 | 1.00 | 1.00 | 1.00 | 2.00 | 3.00 | - | - | - | - | - | - | - | 106 |
Income Taxes | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income | 139.6% | 825 | -2,083 | -3,774 | -3,816 | -4,448 | -4,216 | -5,052 | -4,595 | -4,973 | -4,031 | -8,184 | -3,852 | -4,104 | -2,899 | -10,553 | -1,170 | -4,686 | -4,041 | -3,555 | -7,844 | -5,221 |
Net Income Margin | 60.9% | -0.76* | -1.93* | -2.39* | -2.53* | -2.86* | -3.10* | -3.87* | -5.42* | -4.26* | -3.90* | -2.84* | -2.14* | -1.66* | -1.53* | -1.67* | - | - | - | - | - | - |
Free Cashflow | -24.1% | -2,873 | -2,316 | -4,455 | -4,962 | -4,928 | -5,055 | -3,604 | -4,629 | -6,154 | -4,422 | -3,412 | -6,607 | -5,578 | -2,851 | -5,615 | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Assets | -10.5% | 30.00 | 34.00 | 37.00 | 31.00 | 36.00 | 41.00 | 46.00 | 49.00 | 54.00 | 59.00 | 56.00 | 65.00 | 70.00 | 38.00 | 43.00 | 35.00 | 31.00 | 36.00 | 33.00 | 37.00 | 14.00 |
Current Assets | -15.6% | 18.00 | 21.00 | 23.00 | 27.00 | 33.00 | 38.00 | 43.00 | 46.00 | 51.00 | 55.00 | 54.00 | 60.00 | 64.00 | 32.00 | 37.00 | 29.00 | 26.00 | 31.00 | 29.00 | 33.00 | 3.00 |
Cash Equivalents | -15.0% | 16.00 | 19.00 | 21.00 | 26.00 | 31.00 | 36.00 | 41.00 | 43.00 | 48.00 | 54.00 | 53.00 | 57.00 | 63.00 | 32.00 | 35.00 | 27.00 | 24.00 | 23.00 | 28.00 | 32.00 | 2.00 |
Net PPE | -4.3% | 1.00 | 1.00 | 1.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Goodwill | - | - | - | - | - | - | - | - | - | - | - | - | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 10.00 |
Liabilities | -28.8% | 11.00 | 16.00 | 17.00 | 8.00 | 9.00 | 10.00 | 11.00 | 11.00 | 12.00 | 11.00 | 11.00 | 12.00 | 13.00 | 15.00 | 19.00 | 21.00 | 24.00 | 25.00 | 18.00 | 19.00 | 11.00 |
Current Liabilities | -19.6% | 3.00 | 4.00 | 4.00 | 4.00 | 5.00 | 5.00 | 6.00 | 6.00 | 5.00 | 4.00 | 5.00 | 7.00 | 7.00 | 8.00 | 11.00 | 15.00 | 17.00 | 17.00 | 12.00 | 13.00 | 4.00 |
Shareholder's Equity | 5.7% | 19.00 | 18.00 | 20.00 | 23.00 | 27.00 | 31.00 | 35.00 | 38.00 | 43.00 | 47.00 | 45.00 | 53.00 | 57.00 | 23.00 | 24.00 | 14.00 | 7.00 | 11.00 | 15.00 | 18.00 | 10.00 |
Retained Earnings | 0.3% | -286 | -287 | -285 | -281 | -277 | -273 | -269 | -264 | -259 | -254 | -250 | -242 | -238 | -234 | -231 | -221 | -219 | -215 | -211 | -207 | -199 |
Additional Paid-In Capital | 0.1% | 306 | 306 | 305 | 305 | 305 | 305 | 304 | 303 | 302 | 301 | 296 | 296 | 295 | 258 | 255 | 235 | 227 | 226 | 226 | 226 | 210 |
Shares Outstanding | 0% | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | - | 3,478 | 3,372 | - | 3.00 | 3.00 | 3.00 | 3.00 | 2.00 | - | - | - | - | - | - | - |
Float | - | - | - | - | 10.00 | - | - | - | 16.00 | - | - | - | 58.00 | - | - | - | 44.00 | - | - | - | 17.00 | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Cashflow From Operations | -35.2% | -2,719 | -2,011 | -4,142 | -4,904 | -4,928 | -5,046 | -3,604 | -4,562 | -6,144 | -4,396 | -3,312 | -6,524 | -5,495 | -2,768 | -5,515 | -4,998 | 798 | -4,433 | -3,928 | 15,047 | -3,456 |
Share Based Compensation | 0.5% | 198 | 197 | 206 | 255 | 296 | 279 | 277 | 277 | 281 | 247 | 284 | 299 | 328 | 246 | 303 | 266 | 343 | 331 | 185 | 1,091 | 459 |
Cashflow From Investing | 49.5% | -154 | -305 | -313 | -58.00 | - | -9.00 | - | -67.00 | -10.00 | -26.00 | -100 | - | - | -83.00 | -100 | -2.00 | -96.00 | -9.00 | -14.00 | -25.00 | -10.00 |
Cashflow From Financing | - | - | - | - | - | 53.00 | - | 1,382 | - | -152 | 6,192 | - | - | 37,283 | - | 12,868 | 7,853 | 260 | 3.00 | 4.00 | 14,649 | 3,049 |
Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Income Statement [Abstract] | ||
Revenues | $ 5,885 | $ 1,499 |
Operating expenses: | ||
Research and development | 3,512 | 3,874 |
General and administrative | 1,626 | 2,210 |
Total operating expenses | 5,138 | 6,084 |
Income (loss) from operations | 747 | (4,585) |
Other income (expense): | ||
Interest income | 160 | 222 |
Other expense, net | (82) | (85) |
Total other income, net | 78 | 137 |
Net income (loss) | $ 825 | $ (4,448) |
Net income (loss) per share attributable to common stockholders - basic | $ 0.23 | $ (1.22) |
Net income (loss) per share attributable to common stockholders - diluted | $ 0.23 | $ (1.22) |
Weighted average common shares outstanding - basic | 3,652,285 | 3,650,769 |
Weighted average common shares outstanding - diluted | 3,652,285 | 3,650,769 |
Consolidated Balance Sheets - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 16,300 | $ 19,173 |
Accounts receivable | 570 | 928 |
Prepaid expenses and other current assets | 712 | 742 |
Total current assets | 17,582 | 20,843 |
Property and equipment, net | 1,108 | 1,158 |
Operating lease right-of-use asset | 10,094 | 10,309 |
Long-term restricted cash | 1,472 | 1,472 |
Other long-term assets | 135 | 176 |
Total assets | 30,391 | 33,958 |
Current liabilities: | ||
Accounts payable | 721 | 1,915 |
Accrued expenses and other current liabilities | 1,677 | 947 |
Operating lease liability | 383 | 429 |
Deferred revenue | 363 | 618 |
Total current liabilities | 3,144 | 3,909 |
Deferred revenue, net of current portion | 3,727 | |
Operating lease liability, net of current portion | 8,229 | 8,327 |
Total liabilities | 11,373 | 15,963 |
Commitments and contingencies (Note 10) | ||
Stockholders’ equity: | ||
Preferred Stock, $0.0001 par value — 500,000 shares authorized; 6,746 shares designated Series A convertible preferred stock; no shares issued and outstanding at March 31, 2024 and December 31, 2023 | ||
Common stock, $0.0001 par value — 200,000,000 shares authorized; 3,652,285 shares issued and outstanding at March 31, 2024 and December 31, 2023 | ||
Additional paid-in capital | 305,790 | 305,592 |
Accumulated deficit | (286,772) | (287,597) |
Total stockholders’ equity | 19,018 | 17,995 |
Total liabilities and stockholders’ equity | $ 30,391 | $ 33,958 |